BCOR and BCORL1 mutations in pediatric acute myeloid leukemia.
作者信息
de Rooij Jasmijn D E, van den Heuvel-Eibrink Marry M, Hermkens Malou C H, Verboon Lonneke J, Arentsen-Peters Susan T C J M, Fornerod Maarten, Baruchel Andre, Stary Jan, Reinhardt Dirk, de Haas Valerie, Pieters Rob, Zwaan C Michel
机构信息
Department of Pediatric Oncology/Hematology, Erasmus MC-Sophia Children's Hospital, Rotterdam, The Netherlands.
CHU de Paris - Hôpital Robert Debré, France.
出版信息
Haematologica. 2015 May;100(5):e194-5. doi: 10.3324/haematol.2014.117796. Epub 2015 Jan 16.
Abstract
摘要
相似文献
1
BCOR and BCORL1 mutations in pediatric acute myeloid leukemia.
Haematologica. 2015 May;100(5):e194-5. doi: 10.3324/haematol.2014.117796. Epub 2015 Jan 16.
2
Usefulness of BCOR gene mutation as a prognostic factor in acute myeloid leukemia with intermediate cytogenetic prognosis.
Genes Chromosomes Cancer. 2018 Aug;57(8):401-408. doi: 10.1002/gcc.22542.
3
Age-Related Co-Expression of BCOR and BCORL1 mRNA in Acute Myeloid Leukemia.
Clin Lab. 2020 Aug 1;66(8). doi: 10.7754/Clin.Lab.2020.191119.
4
Clarifying the impact of polycomb complex component disruption in human cancers.
Mol Cancer Res. 2014 Apr;12(4):479-84. doi: 10.1158/1541-7786.MCR-13-0596. Epub 2014 Feb 10.
5
The corepressors BCOR and BCORL1: two novel players in acute myeloid leukemia.
Haematologica. 2012 Jan;97(1):3-5. doi: 10.3324/haematol.2011.057901.
6
BCOR and BCORL1 mutations in myelodysplastic syndromes and related disorders.
Blood. 2013 Oct 31;122(18):3169-77. doi: 10.1182/blood-2012-11-469619. Epub 2013 Sep 18.
7
Loss-of-function mutations in BCOR contribute to chemotherapy resistance in acute myeloid leukemia.
Exp Hematol. 2021 Sep;101-102:42-48.e11. doi: 10.1016/j.exphem.2021.07.005. Epub 2021 Jul 30.
8
[Clinical Characteristics and Prognostic Significance of BCOR/BCORL1 Gene Mutation in Patients with Myelodysplastic Syndromes].
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2020 Dec;28(6):2004-2010. doi: 10.19746/j.cnki.issn.1009-2137.2020.06.034.
9
Acute myeloid leukemia ontogeny is defined by distinct somatic mutations.
Blood. 2015 Feb 26;125(9):1367-76. doi: 10.1182/blood-2014-11-610543. Epub 2014 Dec 30.
10
ETV6 mutations and loss in AML-M0.
Leukemia. 2008 Aug;22(8):1639-43. doi: 10.1038/leu.2008.34. Epub 2008 Feb 28.
引用本文的文献
1
, , and Mutations in Pediatric Leukemias.
Cancers (Basel). 2025 Jul 23;17(15):2443. doi: 10.3390/cancers17152443.
2
Molecular genetics profiling of core-binding factor acute myeloid leukemia in pediatrics.
Ther Adv Hematol. 2025 Apr 16;16:20406207251330064. doi: 10.1177/20406207251330064. eCollection 2025.
3
Comprehensive genomic characterization of hematologic malignancies at a pediatric tertiary care center.
Front Oncol. 2024 Dec 2;14:1498409. doi: 10.3389/fonc.2024.1498409. eCollection 2024.
4
FUS-ERG induces late-onset azacitidine resistance in acute myeloid leukaemia cells.
Sci Rep. 2023 Sep 2;13(1):14454. doi: 10.1038/s41598-023-41230-1.
5
The MLL-Menin Interaction is a Therapeutic Vulnerability in -rearranged AML.
Hemasphere. 2023 Jul 27;7(8):e935. doi: 10.1097/HS9.0000000000000935. eCollection 2023 Aug.
6
Next-Generation Sequencing-Based Genomic Profiling of Children with Acute Myeloid Leukemia.
J Mol Diagn. 2023 Aug;25(8):555-568. doi: 10.1016/j.jmoldx.2023.04.004. Epub 2023 Apr 22.
7
S878G, G116S, A536T, and S3708R tetramutation co-contribute to a pediatric acute myeloid leukemia: Case report and literature review.
Front Pediatr. 2022 Oct 17;10:993952. doi: 10.3389/fped.2022.993952. eCollection 2022.
8
Murine Models of Acute Myeloid Leukemia.
Front Oncol. 2022 Jun 8;12:854973. doi: 10.3389/fonc.2022.854973. eCollection 2022.
9
BCOR gene alterations in hematologic diseases.
Blood. 2021 Dec 16;138(24):2455-2468. doi: 10.1182/blood.2021010958.
10
Loss-of-Function Mutations of Are an Independent Marker of Adverse Outcomes in Intensively Treated Patients with Acute Myeloid Leukemia.
Cancers (Basel). 2021 Apr 26;13(9):2095. doi: 10.3390/cancers13092095.
本文引用的文献
1
Ensembl 2014.
Nucleic Acids Res. 2014 Jan;42(Database issue):D749-55. doi: 10.1093/nar/gkt1196. Epub 2013 Dec 6.
2
BCOR and BCORL1 mutations in myelodysplastic syndromes and related disorders.
Blood. 2013 Oct 31;122(18):3169-77. doi: 10.1182/blood-2012-11-469619. Epub 2013 Sep 18.
3
NUP98/JARID1A is a novel recurrent abnormality in pediatric acute megakaryoblastic leukemia with a distinct HOX gene expression pattern.
Leukemia. 2013 Dec;27(12):2280-8. doi: 10.1038/leu.2013.87. Epub 2013 Mar 27.
4
The corepressors BCOR and BCORL1: two novel players in acute myeloid leukemia.
Haematologica. 2012 Jan;97(1):3-5. doi: 10.3324/haematol.2011.057901.
5
Whole-exome sequencing identifies somatic mutations of BCOR in acute myeloid leukemia with normal karyotype.
Blood. 2011 Dec 1;118(23):6153-63. doi: 10.1182/blood-2011-07-365320. Epub 2011 Oct 19.
6
Somatic mutations in the transcriptional corepressor gene BCORL1 in adult acute myelogenous leukemia.
Blood. 2011 Nov 24;118(22):5914-7. doi: 10.1182/blood-2011-05-356204. Epub 2011 Oct 11.
7
NUP98/NSD1 characterizes a novel poor prognostic group in acute myeloid leukemia with a distinct HOX gene expression pattern.
Blood. 2011 Sep 29;118(13):3645-56. doi: 10.1182/blood-2011-04-346643. Epub 2011 Aug 2.
8
Integrative analysis of type-I and type-II aberrations underscores the genetic heterogeneity of pediatric acute myeloid leukemia.
Haematologica. 2011 Oct;96(10):1478-87. doi: 10.3324/haematol.2010.038976. Epub 2011 Jul 26.
9
Biology, risk stratification, and therapy of pediatric acute leukemias: an update.
J Clin Oncol. 2011 Feb 10;29(5):551-65. doi: 10.1200/JCO.2010.30.7405. Epub 2011 Jan 10.
10
Characterization of CEBPA mutations and promoter hypermethylation in pediatric acute myeloid leukemia.
Haematologica. 2011 Mar;96(3):384-92. doi: 10.3324/haematol.2010.031336. Epub 2010 Dec 6.
Zotero 插件